Cara Therapeutics Inc. buy Needham & Company LLC
Start price
28.03.24
/
50%
€0.87
Target price
28.03.25
€4.62
Performance (%)
-26.37%
Price
26.04.24
€0.64
Summary
This prediction is currently active. The prediction for Cara Therapeutics Inc. disappoints with a performance of -26.37%. This prediction currently runs until 28.03.25. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Cara Therapeutics Inc. | 1.270% |
iShares Core DAX® | 2.594% |
iShares Nasdaq 100 | 3.553% |
iShares Nikkei 225® | 0.687% |
iShares S&P 500 | 2.209% |
Comments by Needham___Company_LL for this prediction
In the thread Cara Therapeutics Inc. diskutieren
Cara Therapeutics, Inc. (NASDAQ: CARA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $5.00 price target on the stock.
Ratings data for CARA provided by MarketBeat
Stopped prediction by Needham___Company_LL for Cara Therapeutics Inc.
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.75
10.04.24
10.04.24
€4.64
10.04.25
10.04.25
-21.32%
26.04.24
26.04.24
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.78
05.03.24
05.03.24
€4.61
05.03.25
05.03.25
-17.78%
26.04.24
26.04.24
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.51
22.01.24
22.01.24
€4.59
22.01.25
22.01.25
25.10%
26.04.24
26.04.24
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.56
18.12.23
18.12.23
€5.50
18.12.24
18.12.24
13.62%
26.04.24
26.04.24
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.60
08.08.23
08.08.23
€20.10
08.08.24
08.08.24
-77.40%
26.04.24
26.04.24
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€4.32
04.04.23
04.04.23
€20.09
04.04.24
04.04.24
-81.49%
05.04.24
05.04.24